The behavior appeared to initially stem from several members of upper management, and it quickly began to permeate throughout all levels of the company.
Peers in parliament's upper chamber voted by 212 to 92 on Monday to allow research using stem cells to develop treatments for killer diseases such as leukaemia, Parkinson's and cancer.